Perrigo's OTC birth control pill aces FDA expert meeting

The jury has spoken, giving a unanimous "yes" to push Perrigo’s birth control tablet Opill over the counter.

Wednesday, experts from a joint FDA meeting of outside experts voted 17 to 0 in favor of Opill’s over-the-counter approval pivot. If approved later this year by the FDA, Opill would become the first OTC daily hormonal birth control pill cleared in the U.S.